Who We Are

PolyMedix is a clinical stage biotechnology company that is developing first-in-class, small-molecule drugs for the treatment of serious acute care conditions.

We are now on Twitter! Follow us to keep up with all the exciting new things coming to PolyMedix!

follow us on twitter follow us on twitter

Press Releases

View All Press Releases

Ed SmithLetter to Shareholders of PolyMedix.pdf

Edward F. Smith, Interim President & CEO
PolyMedix, Inc.

Upcoming Events

View All Upcoming Events


Website by Graphic Success